Geode Capital Management, LLC Endra Life Sciences Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.19 - $0.45 $4,049 - $9,590	21,313 Added 6.58%	344,992 $80,000
Q3 2021 Nov 12, 2021	BUY	$1.38 - $2.15 $9,931 - $15,473	7,197 Added 2.27%	323,679 $559,000
Q2 2021 Aug 13, 2021	BUY	$1.98 - $2.74 $119,160 - $164,898	60,182 Added 23.48%	316,482 $689,000
Q1 2021 May 12, 2021	BUY	$0.8 - $2.85 $153,897 - $548,260	192,372 Added 300.92%	256,300 $666,000
Q1 2020 May 14, 2020	BUY	$0.68 - $2.14 $716 - $2,253	1,053 Added 1.67%	63,928 $46,000
Q2 2019 Aug 14, 2019	BUY	$1.02 - $2.04 $12,006 - $24,012	11,771 Added 23.03%	62,875 $107,000
Q1 2019 May 14, 2019	BUY	$1.65 - $3.29 $5,517 - $11,001	3,344 Added 7.0%	51,104 $84,000
Q4 2018 Feb 13, 2019	BUY	$1.5 - $5.4 $71,640 - $257,904	47,760 New	47,760 $71,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $353M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.